117 related articles for article (PubMed ID: 1182691)
1. Carbamoylation of amino acid, peptides, and proteins by nitrosoureas.
Wheeler GP; Bowdon BJ; Struck RF
Cancer Res; 1975 Nov; 35(11 Pt 1):2974-84. PubMed ID: 1182691
[TBL] [Abstract][Full Text] [Related]
2. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
3. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
Begleiter A; Lam HP; Goldenberg GJ
Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
Baril BB; Baril EF; Laszlo J; Wheeler GP
Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
[TBL] [Abstract][Full Text] [Related]
6. 2-chloroethanol formation as evidence for a 2-chloroethyl alkylating intermediate during chemical degradation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
Reed DJ; May HE; Boose RB; Gregory KM; Beilstein MA
Cancer Res; 1975 Mar; 35(3):568-76. PubMed ID: 1116123
[TBL] [Abstract][Full Text] [Related]
7. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
Tew KD; Wang AL
Mol Pharmacol; 1982 May; 21(3):729-38. PubMed ID: 7110120
[TBL] [Abstract][Full Text] [Related]
8. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
Sariban E; Erickson LC; Kohn KW
Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
[TBL] [Abstract][Full Text] [Related]
9. Microsomal metabolism of nitrosoureas.
Hill DL; Kirk MC; Struck RF
Cancer Res; 1975 Feb; 35(2):296-301. PubMed ID: 234031
[TBL] [Abstract][Full Text] [Related]
10. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
[TBL] [Abstract][Full Text] [Related]
11. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas.
Kohn KW
Cancer Res; 1977 May; 37(5):1450-4. PubMed ID: 851960
[TBL] [Abstract][Full Text] [Related]
12. Effects of nitrosoureas on human DNA polymerase activities from acute and chronic granulocytic leukemia cells.
Chuang RY; Laszlo J; Keller P
Biochim Biophys Acta; 1976 Apr; 425(4):463-8. PubMed ID: 1063042
[TBL] [Abstract][Full Text] [Related]
13. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
[TBL] [Abstract][Full Text] [Related]
14. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
15. Main urinary metabolites of two cysteamine-containing 2-(chloroethyl) nitrosoureas in rats.
Godeneche D; Labarre P; Moreau MF; Madelmont JC; Rapp M; Papon J; Veyre A
Drug Metab Dispos; 1993; 21(1):93-9. PubMed ID: 8095233
[TBL] [Abstract][Full Text] [Related]
16. Modification of calmodulin on Lys-75 by carbamoylating nitrosoureas.
Mann DM; Vanaman TC
J Biol Chem; 1988 Aug; 263(23):11284-90. PubMed ID: 3136156
[TBL] [Abstract][Full Text] [Related]
17. Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Babson JR; Reed DJ; Sinkey MA
Biochemistry; 1977 Apr; 16(8):1584-9. PubMed ID: 856251
[TBL] [Abstract][Full Text] [Related]
18. Chemical stability, alkylating activity, and lipophilicity of 1,1'-ethylene-bis(1-nitrosourea) and related compounds.
Morimoto K; Yamaha T; Nakadate M; Suzuki I
Gan; 1978 Feb; 69(1):139-42. PubMed ID: 640322
[TBL] [Abstract][Full Text] [Related]
19. [Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas].
Wakui A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1327-38. PubMed ID: 6223595
[TBL] [Abstract][Full Text] [Related]
20. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
Bedford P; Eisenbrand G
Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
